Blue Belt gets $40M in debt; Handheld ECG effective for stroke patient monitoring;

@FierceMedDev: AliveCor heart monitor, app added to GreatCall's health-focused smartphone. More | Follow @FierceMedDev

@VarunSaxena2: Chinese government urges hospitals to buy local devices. Story | Follow @VarunSaxena2

@EmilyWFierce: Johnson & Johnson weighs $250M settlement to resolve more hip implant claims. Article | Follow @EmilyWFierce

@MichaelGFierce: @HarvardResearch team uses stem cells to deliver toxic doses to #cancer cells. More | Follow @MichaelGFierce

> Blue Belt Technologies, developer of "smart" surgical instruments, secured $40 billion in a debt financing from CRG, a healthcare-focused investment firm. Release

> iSTAR Medical, an ophthalmic device company successfully implanted the STARfloglaucoma drainage device in the first patient in its European multi-center clinical trial. Release

> 75-year-old stroke patients who regularly screened themselves using a handheld-ECG device were able to more successfully detect problems and save money on treatments. Release

> Hansen Medical ($HNSN), an intravascular robotics development company, launched its third generation Sensei surgical robot, a 3D catheter control system for electrophysiology procedures. Release

Biotech News

@FierceBiotech: $IPXL cans 25% of its R&D staff in a cost-cutting gambit. More | Follow @FierceBiotech

@JohnCFierce: FDA to $SRPT's CEO: You don't hear so well. And that's something you don't see much. Great piece by @DamianFierce. Article | Follow @JohnCFierce

@DamianFierce: Six of @ClevelandClinic's Top 10 Medical Innovations are drugs, and here's a bunch of words on them. Story | Follow @DamianFierce

@EmilyMFierce: What about effect of radiation on adults? Aggressive thyroid cancers in children linked to radiation exposure. News | Follow @EmilyMFierce

> Novartis sets sights on Philly amid a sweeping CAR-T collaboration. Item

> Novo Nordisk bets another $130M on diabetes R&D with new Danish hub. Article

> Clarus and Frazier back a 'backyard' biotech team with $26.5M for epigenetics R&D. More

Pharma News

@FiercePharma: Jobs saved as Boehringer Ingelheim finds Chinese buyer for U.S. plant set to close. Story | Follow @FiercePharma

@EricPFierce: ICYMI: Novorossiya hiring 90 workers for its new plant in New Hampshire. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Top-read in FierceVaccines Thursday: Pfizer beats out Novartis with FDA MenB nod. Article | Follow @CarlyHFierce

> After strong Q3, no $55B deals in AbbVie's future, CEO says. But a smaller one? Maybe. More

> Cipla petitions India to revoke Novartis respiratory drug patents, launches low-cost version of drug. News

Suggested Articles

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.